Target intelligence / Profile preview

RNA, U6 small nuclear 892, pseudogene (RNU6-892P)

Target: RNU6-892P
Molecular classification: Pseudogene, non-coding RNA

Overview

RNU6-892P is a pseudogene in the human genome, annotated based on sequence similarity to the functional U6 small nuclear RNA gene. The U6 small nuclear RNA is an essential component of the spliceosome, participating in the splicing of pre-mRNA in eukaryotes[4]. However, RNU6-892P itself is a non-functional genomic locus that does not encode an active RNA or protein. Pseudogenes like RNU6-892P typically arise via duplication or retrotransposition and accumulate mutations that disable their original function. While certain pseudogenes can exert regulatory effects on gene expression through the production of noncoding RNAs or by acting as miRNA decoys[1][2][5], no functional impact or disease association is documented for RNU6-892P specifically.

Other names: RNU6-892PRNA, U6 small nuclear 892, pseudogene

Mechanism of action

None known

Biological functions

No direct biological function; pseudogenes sometimes regulate parental genes via noncoding RNA mechanisms, such as antisense RNAs or as competing endogenous RNAs in some contexts. However, there is no evidence for functional roles specific to RNU6-892P.

Disease associations

None established. Some pseudogenes have regulatory or disease associations (e.g., as ceRNAs or lncRNAs in cancer), but RNU6-892P has no documented role in disease.

Safety considerations

None reported; pseudogenes are not targeted in therapy and have no safety concerns as therapeutic agents.

Interacting drugs

None known

Biomarkers

None reported

Beyond the preview

Go deeper on RNA, U6 small nuclear 892, pseudogene (RNU6-892P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 892, pseudogene (RNU6-892P).

Explore the full profile